- PrimeView
- Published:
Parkinson disease-associated cognitive impairment
Nature Reviews Disease Primers volume 7, Article number: 46 (2021)
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Mesenchymal stromal cell biotherapy for Parkinson’s disease premotor symptoms
Chinese Neurosurgical Journal Open Access 13 October 2023
-
Neuroprotective effects of morroniside from Cornus officinalis sieb. Et zucc against Parkinson’s disease via inhibiting oxidative stress and ferroptosis
BMC Complementary Medicine and Therapies Open Access 01 July 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 /Â 30Â days
cancel any time
Subscribe to this journal
Receive 1 digital issues and online access to articles
$119.00 per year
only $119.00 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
This PrimeView highlights the epidemiology, diagnosis, mechanisms, quality of life effects and treatment of cognitive impairment in patients with Parkinson disease.
Rights and permissions
About this article
Cite this article
Parkinson disease-associated cognitive impairment. Nat Rev Dis Primers 7, 46 (2021). https://doi.org/10.1038/s41572-021-00286-x
Published:
DOI: https://doi.org/10.1038/s41572-021-00286-x
